Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The settlements with the patient assistance charities Good Days and Patient Access Network Foundation were the first with foundations linked to an industry-wide probe that has resulted in $840 million in settlements with drugmakers. Both foundations provide assistance to patients seeking to pay out-of-pocket costs for medications. Good Days agreed to pay $2 million while PAN Foundation agreed to pay $4 million. Neither admitted wrongdoing. Good Days in a statement said the settlement will allow it to concentrate on providing help to people in need of life-saving medications. PAN said the settlement involved "legacy matters" rather than its current operations. Drug companies are prohibited from subsidizing co-payments for patients enrolled in the government's Medicare healthcare program for those aged 65 and older. Companies may donate to non-profits providing co-pay assistance as long as they are independent. But the government has alleged that various drugmakers have used charities like Good Days and PAN as means to improperly pay the co-pay obligations of Medicare patients using their drugs, in violation of the Anti-Kickback Statute. The department said Good Days, previously known as the Chronic Disease Fund, from 2010 to 2014 conspired with companies including Novartis AG, Astellas and Questcor, now owned by Mallinckrodt Plc, to pay kickbacks to Medicare patients using their drugs. Those drugs included H.P. Acthar Gel, an expensive treatment for a rare infant seizure disorder and multiple sclerosis that is subject of a related lawsuit by the government against Mallinckrodt over Questcor's donations to the charity. The Justice Department said Questcor from 2010 to 2014 used the charity as a conduit to improperly subsidize patients' copays, allowing it to keep raising prices for Acthar, whose price increased from $50 per vial in 2001 to $32,200 in 2014. Mallinckrodt declined to comment. It has said it believed its actions were lawful. PAN similarly permitted Bayer AG, Astellas, Dendreon Pharmaceuticals and Amgen Inc to use it as a conduit to pay patients kickbacks, according to the government's allegations. Astellas and Amgen in April agreed to pay $100 million and $24.75 million, respectively, to resolve related claims. Dendreon said it takes compliance seriously. Novartis declined to comment. The other companies' representatives did not respond to requests for comment.
[A]: Two charities to pay $6 million to resolve U.S. pharma kickback probe.

[Q]: The N.C. Department of Health and Human Services said in a news release on Tuesday that it's working with the Buncombe and Henderson County health departments to track down additional information. Legionella bacteria can become a health concern when they grow and spread in human-made water systems like hot water tanks, air conditioning systems and other sources that are not properly maintained. State Epidemiologist Dr. Zack Moore said it's not yet known if people attending the fair might have been exposed to Legionella bacteria. Moore says people who attended the fair and are experiencing cough, fever or shortness of breath should call their health care provider right away.
[A]: 2 health departments investigate Legionnaires' disease.

[Q]: "In his address to a joint session of Congress, President Barack Obama brought up the most explosive charge to emerge in the health care debate: the specter of ""death panels."" ""Some of people's concerns (about the health care legislation) have grown out of bogus claims spread by those whose only agenda is to kill reform at any cost,"" Obama told lawmakers and a national television audience on Sept. 9, 2009. ""The best example is the claim, made not just by radio and cable talk show hosts, but by prominent politicians, that we plan to set up panels of bureaucrats with the power to kill off senior citizens. Now, such a charge would be laughable if it weren't so cynical and irresponsible. It is a lie, plain and simple."" The president was referring to a notion most prominently raised by former Alaska Republican Gov. Sarah Palin in a note posted on her Facebook page on Aug. 7, 2009. ""And who will suffer the most when they ration care?"" Palin wrote. ""The sick, the elderly, and the disabled, of course. The America I know and love is not one in which my parents or my baby with Down Syndrome will have to stand in front of Obama's 'death panel' so his bureaucrats can decide, based on a subjective judgment of their 'level of productivity in society,' whether they are worthy of health care. Such a system is downright evil."" We have read all 1,000-plus pages of the Democratic bill and examined versions in various committees. There is no panel in any version of the health care bills in Congress that judges a person's ""level of productivity in society"" to determine whether someone is ""worthy"" of health care. When we first assessed Palin's claim on Aug. 7, 2009, we gave it our lowest rating . Palin may have jumped to a conclusion about the Obama administration's efforts to promote comparative effectiveness research. Such research has nothing to do with evaluating patients for ""worthiness."" Rather, comparative effectiveness research finds out which treatments work better than others. The health reform bill being considered in the House of Representatives says that a Comparative Effectiveness Research Center shall ""conduct, support, and synthesize research"" that looks at ""outcomes, effectiveness, and appropriateness of health care services and procedures in order to identify the manner in which diseases, disorders, and other health conditions can most effectively and appropriately be prevented, diagnosed, treated, and managed clinically."" The idea here, which Obama and his budget director Peter Orszag have discussed many times, is to make it easier for doctors, health care workers, insurance companies and patients to find out which treatments are the most effective, as determined by clinical studies and other research. The House bill states in the section creating the Comparative Effectiveness Research Center and an oversight commission that ""nothing in this section shall be consd to permit the Commission or the Center to mandate coverage, reimbursement, or other policies for any public or private payer."" In other words, comparative effectiveness research will tell you whether treatment A is better than treatment B. But the bill as written won't mandate which treatment doctors and patients have to select. Nothing has emerged to suggest to us that the death panels claim is any more today than it was when Palin first floated it. We still rate it as today. In our book, that counts as a ""lie, plain and simple."" So we find Obama's claim ."
[A]:
The claim ... that we plan to set up panels of bureaucrats with the power to kill off senior citizens ... is a lie, plain and simple.